[Ip-health] 15th WHO EML out now.

[Ellen 't Hoen]

Zocor - generic name: simvastatin.
May I suggest the use of the generic names of medicines instead of the bran=
d
name when making postings on ip-health. This is in general part of good
medical practice.

Best,

Ellen 't Hoen
MSF Access to Essential Medicines Campaign
Ellen.t.hoen@paris.msf.org


On 28/4/07 21:23, "Caroline Gallant" <caroline.gallant@mail.mcgill.ca>
wrote:

> Hello All
>
> I would like to also highlight the inclusion of Zocor, a drug to help
> treat cardiovascular disease, on the WHO EML.
>
> Authors of the application include students Sandeep Kishore, Ben
> Herbstman and librarians helen-ann brown and Patricia Mongelia, all
> from Weill Cornell Medical College. The effort was completed by the
> student-led Universities Allied for Essential Medicines (UAEM) at the
> Weill Cornell/ Rockefeller/ Sloan-Kettering Tri-Institutional program
> and a group in Modena, Italy.
>
> More info below.
>
> Best,
> Caroline Gallant
> UAEM
> McGill University
>
> ___
>
> NEW YORK =8B The World Health Organization (WHO) announced last week a
> move to make the life-saving, blockbuster cholesterol-lowering
> medicine Zocor widely available globally. The WHO Committee on the
> Selection and Use of Essential Medicines has included generic versions
> of the blockbuster, cholesterol-lowering medicines referred to as
> statins available on the WHO Model List of Essential Medicines.
> Statins are proven, blockbuster medicines which are #1 and #2 spot on
> best-selling medicines in the U.S. In now qualifying for the Model
> List, statins will be available for drug donation by all United
> Nations' (UN) groups and major philanthropic foundations.
>
> The WHO estimates that heart or cardiovascular disease, is the leading
> cause of death globally. Cardiovascular disease is no longer a
> "Western disease" as nearly 80% of all deaths to heart disease are in
> the poorest countries in the developing world. Despite fast-maturing
> economies, these countries often lack the purchasing power for
> life-saving, essential medicines.
>
> The WHO's Model List substantially improves access to these medicines.
> Most if not all donor agencies will only purchase medicines on the
> Model List for drug donations. In additional, non-governmental
> organizations and charities (e.g. The Clinton Foundation) use this
> list as a guide to their donations. In certain cases, pharmaceutical
> firms offer for striking price discounts for "essential medicines.".
> The Model List, itself, is used as a purchasing list by 156 countries
> with limited resources that are helped by this international expert
> advice in setting their priorities for purchasing and distributing
> essential medicines.
>
> Authors of the application include students Sandeep Kishore, Ben
> Herbstman and librarians helen-ann brown and Patricia Mongelia, all
> from Weill Cornell Medical College. The effort was completed by the
> student-led Universities Allied for Essential Medicines (UAEM) at the
> Weill Cornell/ Rockefeller/ Sloan-Kettering Tri-Institutional program
> and a group in Modena, Italy.
>
> International experts supported the students' work including Srinath
> Reddy of the All-India Institute of Medical Sciences, Derek Yach the
> previous director Rockefeller Global Health program and former
> director of the WHO program on non-communicable diseases and Jonathan
> Quick former Director of the WHO Essential Drugs program.
>
> UAEM is a international, non-profit student group that seeks to
> leverage university resources to increase the access of essential
> medicines globally, particularly for low-income countries. On April
> 18th, university students from across the U.S. will come together in a
> National Day of Action (NDA) to demonstrate collective power of
> university students/faculty in improving global public health.
>
> CONTACT:
> sunny.kishore@gmail.com
> 917-733-1973
>
> The Essential Medicines program established the essential medicines
> concept, that a limited list of essential medicines to meet the needs
> of the vast majority of a population be purchased and made available
> to everyone in the population before money is spent purchasing other
> medicines. One hundred and fifty-six countries have adopted this
> concept in principle. This Expert Committee advises the Director
> General of WHO about policies and issues related to essential
> medicines, and regularly updates a Model List of Essential Medicines
> to show how the concept can be implemented. In 1977, the first Model
> List contained 186 drugs. Now, 30 years later, it contains somewhat
> over 300. The Model List, itself, is used as a purchasing list by many
> countries with limited resources that are helped by this international
> expert advice in setting their priorities for purchasing essential
> medicines. Most if not all donor agencies such as UNICEF will only
> purchase medicines on the Model List. In additional, non-governmental
> organizations and charities use this list as a guide to their
> donations. This WHO program has had global impact on making essential
> medicines available to those who need them.
>
> On 13-Apr-07, at 5:14 PM, Aelaf Worku wrote:
>
> There are some interesting changes regarding epilepsy and peds
> formulations but otherwise this report is lean with respect
> to chronic disease treatments.  Below are both he list and the
> accompanying press release.
>
> http://www.who.int/medicines/news/EML15_WHO_NoteForMedia17_2007en.pdf
>
> http://www.who.int/medicines/publications/EML15.pdf
>
> Aelaf D. Worku
> Medical Student, IV
> Mount Sinai School of Medicine
> 917-992-0101
> javascript:parent.send('smtp')
> "Everything that is really great and inspiring is created by the
> individual who can labor in freedom."
> -Albert Einstein
> _______________________________________________
> Ip-health mailing list
> Ip-health@lists.essential.org
> http://lists.essential.org/mailman/listinfo/ip-health
>
> _______________________________________________
> Ip-health mailing list
> Ip-health@lists.essential.org
> http://lists.essential.org/mailman/listinfo/ip-health